CTCBIO Inc (060590) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.079x

Based on the latest financial reports, CTCBIO Inc (060590) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.64 Billion ≈ $3.82 Million USD) by net assets (₩71.75 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CTCBIO Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how CTCBIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 060590 total debt and obligations for a breakdown of total debt and financial obligations.

CTCBIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CTCBIO Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sensus Healthcare Inc NASDAQ:SRTS	0.048x
Fortune Minerals Limited TO:FT	0.105x
Immutep Ltd AU:IMM	-0.233x
Chemfab Alkalis Limited NSE:CHEMFAB	0.030x
VYTRUS BIOTECH EO -01 F:V5P	N/A
Lacroix Group SA PA:LACR	0.145x
China Fangda Group Co Ltd SHE:200055	0.006x
Gmb Korea KO:013870	0.023x

Annual Cash Flow Conversion Efficiency for CTCBIO Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of CTCBIO Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩69.62 Billion ≈ $47.18 Million	₩4.50 Billion ≈ $3.05 Million	0.065x	-40.69%
2023-12-31	₩75.44 Billion ≈ $51.13 Million	₩8.22 Billion ≈ $5.57 Million	0.109x	-42.66%
2022-12-31	₩95.96 Billion ≈ $65.03 Million	₩18.22 Billion ≈ $12.35 Million	0.190x	+150.02%
2021-12-31	₩85.01 Billion ≈ $57.61 Million	₩6.46 Billion ≈ $4.38 Million	0.076x	+1036.38%
2020-12-31	₩76.32 Billion ≈ $51.72 Million	₩510.09 Million ≈ $345.68K	0.007x	-70.18%
2019-12-31	₩74.74 Billion ≈ $50.65 Million	₩1.68 Billion ≈ $1.14 Million	0.022x	+178.74%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩-2.47 Billion ≈ $-1.68 Million	-0.028x	-813.17%
2017-12-31	₩73.98 Billion ≈ $50.14 Million	₩295.30 Million ≈ $200.12K	0.004x	-94.71%
2016-12-31	₩90.89 Billion ≈ $61.60 Million	₩6.86 Billion ≈ $4.65 Million	0.076x	+420.86%
2015-12-31	₩99.14 Billion ≈ $67.19 Million	₩1.44 Billion ≈ $974.04K	0.014x	+456.42%
2014-12-31	₩85.49 Billion ≈ $57.94 Million	₩-347.74 Million ≈ $-235.66K	-0.004x	-113.69%
2013-12-31	₩92.23 Billion ≈ $62.50 Million	₩2.74 Billion ≈ $1.86 Million	0.030x	--

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$63.43 Million

₩93.60 Billion KRW

Market Cap Rank

#20960 Global

#1294 in Korea

Share Price

₩3915.00

Change (1 day)

+0.13%

52-Week Range

₩3620.00 - ₩7450.00

All Time High

₩18000.00